Medicinova Inc (MNOV)

Business: MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States.

IPO Date: 08-Feb-2005

Co-Founder, Pres, CEO & Exec. Director: Dr. Yuichi Iwaki M.D., Ph.D.

Chief Medical Officer & Director: Dr. Kazuko Matsuda M.D., M.P.H., MPH, Ph.D.

Listing: NASDAQ: MNOV

Country: United States

Headquarters: La Jolla, CA

Website: https://www.medicinova.com

Market cap: $121.14 Mln

Revenue (TTM): $1.82 Mln

Earnings (TTM): $-13.33 Mln

Cash: $67.70 Mln

Total Debt: $0.16 Mln

Insider's Holding: 3.01%

Liquidity: Low

52 Week range: $2.09 - 4.65

Shares outstanding: 49,046,200

10 Years Aggregate:

• CFO: $-80.76 Mln
• EBITDA: $-110.48 Mln
• Net Profit: $-106.66 Mln